Sequence selectivity of azinomycin B in DNA alkylation and cross-linking: a QM/MM study

Dhurairajan Senthilnathan1, Anbarasan Kalaiselvan, Ponnambalam Venuvanalingam

  • 1School of Chemistry, Bharathidasan University, Tiruchirappalli, 620024, India.

Insights

Azinomycin B, an antitumor drug, alkylates DNA's guanine base, blocking tumor growth. Computational modeling revealed a two-step mechanism, with mono-alkylation kinetically controlled and bis-alkylation thermodynamically controlled.

Area of Science:

  • Computational Chemistry
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Azinomycin B is a known antitumor agent that functions by cross-linking DNA.
  • The precise mechanism and selectivity of this DNA alkylation are not fully understood.
  • Understanding this process is crucial for developing more effective cancer therapies.

Purpose of the Study:

  • To elucidate the reaction mechanism and sequence selectivity of Azinomycin B's DNA alkylation.
  • To investigate the roles of the aziridine and epoxide rings in the alkylation process.
  • To determine the kinetic and thermodynamic control of mono- and bis-alkylation.

Main Methods:

  • Utilized the ONIOM (B3LYP/6-31+g(d):UFF) method for theoretical modeling.
  • Validated ONIOM results with full quantum mechanics calculations.
  • Incorporated solvent effects using polarized continuum model calculations.

Main Results:

  • Guanine was identified as the most reactive purine base towards Azinomycin B.
  • Alkylation occurs sequentially: first the aziridine ring at C10, then the epoxide ring at C21.
  • Mono-alkylation is kinetically controlled, while bis-alkylation is thermodynamically controlled.
  • Solvent effects showed minimal impact on the reaction mechanism compared to gas-phase calculations.

Conclusions:

  • The study provides a detailed computational understanding of Azinomycin B's DNA alkylation mechanism.
  • The findings highlight the differential kinetic and thermodynamic control governing mono- and bis-alkylation.
  • This mechanistic insight can inform the design of novel antitumor agents targeting DNA.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...